Lawfare's Quinta Jurecic on what's next for the January 6th Committee and the steps Congress can take to safeguard American democracy.
A scientific advisory panel voted 8 to 7 to recommend that the strongest possible safety warning be added to the labeling for certain drugs used to treat attention-deficit/hyperactivity disorder. A panel talks about what’s behind this recommendation and how these drugs are being used and abused.
- Dr. Steven Nissen Cardiologist at the Cleveland Clinic and a member of the FDA advisory panel that voted to recommend the strongest possible safety warning on certain drugs used to treat AD/HD
- Dr. Jay Salpekar Director of outpatient psychiatry services at Children's National Medical Center
- Dr. Lawrence H. Diller Behavioral developmental pediatrician practicing in Walnut Creek, Ca. and a member of the clinical faculty at the University of California--San Francisco. Author of "Running on Ritalin."
- Lew Mills Psychotherapist in private practice in San Francisco who is taking medication for AD/HD, as are his two children
Most Recent Shows
Susan Glasser and Peter Baker are veteran political journalists who closely covered the presidency of Donald Trump, he as the New York Times chief White House correspondent, she as a…
For months it looked like Russia was waging – and winning -- a battle of attrition. But last week Ukrainian forces made dramatic gains on the battlefield, retaking vast areas…
From McCarthyism to January Sixth, best-selling author David Corn says the G.O.P has a long history of using paranoia, grievance, and tribalism for political gain. His new book is "American Psychosis."